3B Blackbio

{
  "main_header": {
    "sid": 418147,
    "name": "3B Blackbio",
    "stock_name": "3B Blackbio",
    "full_name": "3B Blackbio DX Ltd",
    "name_url": "stocks-analysis/3b-blackbio",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,240.00",
    "chg": 33.3,
    "chgp": "2.76%",
    "dir": 1,
    "prev_price": "1,206.70",
    "mcapval": "1,043.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532067,
    "symbol": "3BBLACKBIO",
    "ind_name": "Healthcare Services",
    "ind_code": 18,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE994E01018",
    "curr_date": "Jun 10, 03:40 PM",
    "curr_time": "15:43 PM",
    "last_traded_at": "Jun 10, 03:40 PM IST",
    "bse_nse_vol": "64.8 k",
    "exc_status": "Active",
    "traded_date": "Jun 10, 2026",
    "traded_date_str": "2026 06 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/3b-blackbio-418147-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "3B Blackbio DX Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-4041003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/3BBlackbioDXLtd_mojoScore_4041003.png",
        "date": "2026-06-09 10:10:21",
        "description": "3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 June 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "3B Blackbio DX Ltd Falls to 52-Week Low of Rs 1083.5 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-falls-to-52-week-low-of-rs10835-amidst-market-downturn-4030207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/3BBlackbioDXLtd_priceRelatedfactors_4030207.png",
        "date": "2026-06-02 09:42:30",
        "description": ""
      },
      {
        "title": "3B Blackbio DX Ltd Falls to 52-Week Low of Rs 1090 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-falls-to-52-week-low-amid-market-pressure-4026808",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/3BBlackbioDXLtd_priceRelatedfactors_4026808.png",
        "date": "2026-06-01 15:05:31",
        "description": "A sharp decline in 3B Blackbio DX Ltd shares has pushed the stock to a fresh 52-week low of Rs 1090 on 1 Jun 2026, marking a significant 12.38% intraday drop amid heightened volatility. This fall comes despite recent quarterly profit growth, underscoring a complex interplay of valuation concerns and market sentiment weighing on the micro-cap healthcare services company."
      },
      {
        "title": "Are 3B Blackbio DX Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-3b-blackbio-dx-ltd-latest-results-good-or-bad-4023885",
        "imagepath": "",
        "date": "2026-05-30 19:49:52",
        "description": "The latest financial results for 3B Blackbio DX Ltd for the quarter ended March 2026 reveal a complex operational landscape characterized by contrasting trends in revenue and profitability. The company reported net sales of ₹35.43 crores, reflecting a significant year-on-year growth of 57.47% compared to ₹22.50 crores in the same quarter last year. However, this growth was accompanied by a notable quarter-on-quarter decline of 29.63% from ₹50.35 crores in the previous quarter, indicating potential revenue volatility.\n\nIn terms of profitability, the consolidated net profit stood at ₹9.56 crores, which represents a year-on-year increase of 13.81% from ₹8.40 crores in the same quarter last year. Nonetheless, this figure marked a sharp decline of 56.01% compared to the previous quarter, raising concerns about the sustainability of profit levels. The profit after tax (PAT) margin contracted to 27.66%, down from ..."
      },
      {
        "title": "3B Blackbio DX Q4 FY26: Profit Plunge Overshadows Revenue Growth Amid Rising Costs",
        "link": "https://www.marketsmojo.com/news/result-analysis/3b-blackbio-dx-q4-fy26-profit-plunge-overshadows-revenue-growth-amid-rising-costs-4022732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/3BBlackbioDX_quaterlyResult_4022732.png",
        "date": "2026-05-29 22:18:56",
        "description": "3B Blackbio DX Ltd., a micro-cap healthcare services company with a market capitalisation of ₹1,064.00 crores, posted a sharp 56.01% quarter-on-quarter decline in consolidated net profit to ₹9.56 crores in Q4 FY26, despite reporting a robust 57.47% year-on-year revenue growth to ₹35.43 crores. The disappointing bottom-line performance was primarily driven by a dramatic surge in employee costs and a significant spike in depreciation expenses, which more than offset the company's top-line expansion."
      },
      {
        "title": "3B Blackbio DX Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-4019933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/3BBlackbioDXLtd_mojoScore_4019933.png",
        "date": "2026-05-29 10:10:42",
        "description": "3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-faces-bearish-momentum-amid-technical-downgrade-4004274",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/3BBlackbioDXLtd_technicaldot_4004274.png",
        "date": "2026-05-22 08:01:28",
        "description": "3B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from Hold to Sell by MarketsMOJO, accompanied by a 4.77% drop in daily price, reflects growing investor caution amid weakening price action and mixed technical signals."
      },
      {
        "title": "When is the next results date for 3B Blackbio DX Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-3b-blackbio-dx-ltd-4003888",
        "imagepath": "",
        "date": "2026-05-21 23:18:58",
        "description": "The next results date for 3B Blackbio DX Ltd is scheduled for 29 May 2026...."
      },
      {
        "title": "3B Blackbio DX Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-3996618",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/3BBlackbioDXLtd_mojoScore_3996618.png",
        "date": "2026-05-18 10:10:43",
        "description": "3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 308,
    "sid": "418147",
    "stock_news_url": "https://www.marketsmojo.com/news/3b-blackbio-dx-418147"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "03-Jun-2026",
      "details": "Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and Financial Year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "01-Jun-2026",
      "details": "Audio Recording of Analysts/Investors Call pertaining to the Audited Financial Results for the quarter and financial year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-May-2026",
      "details": "Submission of Newspaper Publication",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "3B Blackbio DX Ltd has declared <strong>40%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

3B Blackbio DX Ltd is Rated Sell

2026-06-09 10:10:21

3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 June 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

3B Blackbio DX Ltd Falls to 52-Week Low of Rs 1083.5 as Sell-Off Deepens

2026-06-02 09:42:30

Read full news article

3B Blackbio DX Ltd Falls to 52-Week Low of Rs 1090 as Sell-Off Deepens

2026-06-01 15:05:31

A sharp decline in 3B Blackbio DX Ltd shares has pushed the stock to a fresh 52-week low of Rs 1090 on 1 Jun 2026, marking a significant 12.38% intraday drop amid heightened volatility. This fall comes despite recent quarterly profit growth, underscoring a complex interplay of valuation concerns and market sentiment weighing on the micro-cap healthcare services company.

Read full news article

Are 3B Blackbio DX Ltd latest results good or bad?

2026-05-30 19:49:52

The latest financial results for 3B Blackbio DX Ltd for the quarter ended March 2026 reveal a complex operational landscape characterized by contrasting trends in revenue and profitability. The company reported net sales of ₹35.43 crores, reflecting a significant year-on-year growth of 57.47% compared to ₹22.50 crores in the same quarter last year. However, this growth was accompanied by a notable quarter-on-quarter decline of 29.63% from ₹50.35 crores in the previous quarter, indicating potential revenue volatility. In terms of profitability, the consolidated net profit stood at ₹9.56 crores, which represents a year-on-year increase of 13.81% from ₹8.40 crores in the same quarter last year. Nonetheless, this figure marked a sharp decline of 56.01% compared to the previous quarter, raising concerns about the sustainability of profit levels. The profit after tax (PAT) margin contracted to 27.66%, down from ...

Read full news article

3B Blackbio DX Q4 FY26: Profit Plunge Overshadows Revenue Growth Amid Rising Costs

2026-05-29 22:18:56

3B Blackbio DX Ltd., a micro-cap healthcare services company with a market capitalisation of ₹1,064.00 crores, posted a sharp 56.01% quarter-on-quarter decline in consolidated net profit to ₹9.56 crores in Q4 FY26, despite reporting a robust 57.47% year-on-year revenue growth to ₹35.43 crores. The disappointing bottom-line performance was primarily driven by a dramatic surge in employee costs and a significant spike in depreciation expenses, which more than offset the company's top-line expansion.

Read full news article

3B Blackbio DX Ltd is Rated Sell

2026-05-29 10:10:42

3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-05-22 08:01:28

3B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from Hold to Sell by MarketsMOJO, accompanied by a 4.77% drop in daily price, reflects growing investor caution amid weakening price action and mixed technical signals.

Read full news article

When is the next results date for 3B Blackbio DX Ltd?

2026-05-21 23:18:58

The next results date for 3B Blackbio DX Ltd is scheduled for 29 May 2026....

Read full news article

3B Blackbio DX Ltd is Rated Sell

2026-05-18 10:10:43

3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News